Tender Details
Tender Title / Description
| Tender Title | Re-tender for the procurement of specialty drugs for the year 2026-27 |
|---|---|
| Tender Description | adenosine inj ip 3 mg/ml amphotericin b inj ip 50 mg/ml ampicillin and sulbactam for inj each vial contains ampicillin 1 g and sulbactam 0.5 g artesunate +(sulphadoxine + pyremethamine) each combi blister pack contains; [3 tablets of artesunate (each 200 mg) and 2 tablets of sulphadoxine + pyremethamine (each 750 mg + 37.5 mg)] or [3 tablets of artesunate (each 200 mg) and 3 tablets of sulphadoxine + pyremethamine (each 500 mg + 25 mg)] artesunate inj ip 60 mg aztreonam inj usp 1 gm barium sulphate suspension bp/usp 95% w/v bethanechol chloride tab bp 25 mg calcitriol tab 0.25 mcg ceftazidime and avibactam inj each vial contains ceftazidime pentahydrate equivalent to ceftazidime 2 g and avibactam sodium equivalent to avibactam 0.5 g cyclosporine cap ip 100 mg dapsone tab ip 100 mg darifenacin prolonged release tab ip 7.5 mg desonide lotion 0.05% dicumarol tab 25 mg digoxin paediatric solution ip 50 mcg/ml doxycycline inj 100 mg d-penicillamine cap |
| Comments | adenosine inj ip 3 mg/ml amphotericin b inj ip 50 mg/ml ampicillin and sulbactam for inj each vial contains ampicillin 1 g and sulbactam 0.5 g artesunate +(sulphadoxine + pyremethamine) each combi blister pack contains; [3 tablets of artesunate (each 200 mg) and 2 tablets of sulphadoxine + pyremethamine (each 750 mg + 37.5 mg)] or [3 tablets of artesunate (each 200 mg) and 3 tablets of sulphadoxine + pyremethamine (each 500 mg + 25 mg)] artesunate inj ip 60 mg aztreonam inj usp 1 gm barium sulphate suspension bp/usp 95% w/v bethanechol chloride tab bp 25 mg calcitriol tab 0.25 mcg ceftazidime and avibactam inj each vial contains ceftazidime pentahydrate equivalent to ceftazidime 2 g and avibactam sodium equivalent to avibactam 0.5 g cyclosporine cap ip 100 mg dapsone tab ip 100 mg darifenacin prolonged release tab ip 7.5 mg desonide lotion 0.05% dicumarol tab 25 mg digoxin paediatric solution ip 50 mcg/ml doxycycline inj 100 mg d-penicillamine cap |
Important Dates
| Published Date | |
|---|---|
| Due Date | 28 Mar 2026 00:00:00 |
Estimate and EMD
| Estimated Value | 0.0 |
|---|---|
| EMD | 0 INR |
| Processing Fee | 0 INR |